Sabra Healthcare REIT (NASDAQ:SBRA) Stock: Insider Michael Foster Sells 10,000 Shares

Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Director Michael Foster sold 10,000 shares of Sabra Healthcare REIT stock in a transaction that occurred on Wednesday, November 11th. The shares were sold at an average price of $20.98, for a total value of $209,800.00. Following the completion of the transaction, the director owned 72,834 shares of the company’s stock, valued at approximately $1,528,057.32. The trade was a 12.07% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Sabra Healthcare REIT Stock Performance

Shares of Sabra Healthcare REIT stock traded down $0.12 on Friday, reaching $20.44. 2,327,185 shares of the company were exchanged, compared to its average volume of 2,722,799. The company has a debt-to-equity ratio of 0.86, a quick ratio of 1.21 and a current ratio of 1.21. The company’s 50-day moving average is $19.88 and its two-hundred day moving average is $20.04. The firm has a market cap of $5.35 billion, a price-to-earnings ratio of 73.00, a P/E/G ratio of 1.79 and a beta of 0.68. Sabra Healthcare REIT, Inc. has a 1-year low of $17.53 and a 1-year high of $22.77.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its quarterly earnings results on Monday, November 2nd. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.16 by ($0.05). Sabra Healthcare REIT had a return on equity of 2.55% and a net margin of 7.78%. The company had revenue of $249.57 million during the quarter, compared to the consensus estimate of $236.64 million. During the same period last year, the business posted $0.38 EPS. The company’s revenue for the quarter was up 31.4% on a year-over-year basis. As a group, research analysts expect that Sabra Healthcare REIT, Inc. will post 1.52 earnings per share for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, November 30th. Shareholders of record on Friday, November 13th will be given a $0.30 dividend. The ex-dividend date of this dividend is Friday, November 13th. This represents a $1.20 annualized dividend and a yield of 5.9%. Sabra Healthcare REIT’s dividend payout ratio (DPR) is currently 428.57%.

Hedge Funds Weigh In On Sabra Healthcare REIT

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Versant Capital Management Inc increased its position in Sabra Healthcare REIT by 70.0% in the 2nd quarter. Versant Capital Management Inc now owns 1,465 shares of the real estate investment trust’s stock valued at $29,000 after acquiring an additional 603 shares during the period. Root Financial Partners LLC bought a new stake in Sabra Healthcare REIT during the 3rd quarter valued at $34,000. Heritage Family Offices LLP bought a new stake in Sabra Healthcare REIT during the 3rd quarter valued at $45,000. Mather Group LLC. boosted its position in Sabra Healthcare REIT by 34,550.0% during the 3rd quarter. Mather Group LLC. now owns 2,772 shares of the real estate investment trust’s stock worth $55,000 after acquiring an additional 2,764 shares during the period. Finally, Integrated Wealth Concepts LLC acquired a new position in Sabra Healthcare REIT during the 2nd quarter worth $61,000. 99.40% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several equities analysts have recently issued reports on SBRA shares. Deutsche Bank reissued a “buy” rating on shares of Sabra Healthcare REIT in a report on Wednesday, July 22nd. Barclays dropped their price objective on shares of Sabra Healthcare REIT from $23.00 to $21.00 and set an “equal weight” rating on the stock in a report on Tuesday, October 13th. Raymond James Financial raised shares of Sabra Healthcare REIT from an “underperform” rating to a “market perform” rating in a report on Thursday, August 6th. Wells Fargo & Company cut their price objective on shares of Sabra Healthcare REIT from $23.00 to $21.00 and set an “overweight” rating on the stock in a research report on Monday, October 19th. Finally, Truist Financial boosted their target price on shares of Sabra Healthcare REIT from $22.00 to $24.00 and gave the company a “buy” rating in a research note on Wednesday, July 22nd. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and six have given a Hold rating to the company. According to MarketBeat, Sabra Healthcare REIT currently has a consensus rating of “Moderate Buy” and a consensus target price of $21.67.

About Sabra Healthcare REIT

Sabra Health Care REIT, Inc. is a real estate investment trust that owns and invests in properties used to provide healthcare and senior living services. Its portfolio includes skilled nursing and transitional care facilities, senior housing communities, behavioral health facilities, and specialty hospitals. Sabra generally leases its properties to healthcare and senior living operators, providing real estate that supports their services. The company’s properties are located in the United States and Canada.